Skip to main content

Genalyte to Collaborate with Davis Center on Diabetes Panel

NEW YORK (GenomeWeb News) – Genalyte today said that it has inked an agreement with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to collaborate on the further development of multiplexed antigen panels for the early detection of T1D.

The San Diego-based multiplex array technology firm also announced the launch of its Type 1 diabetes antigen panel, which runs on its Maverick Detection System. The firm said the panel is the "first multiplexed assay that measures seven autoantibodies associated with the destruction of pancreatic islet cells seen in type 1 diabetes."

Genalyte provided few details regarding the collaboration with the Davis Center, other than noting that it will involve research being carried out by George Eisenbarth and Liping Yu. Further terms were not disclosed.

"The unique capabilities of our Maverick detection platform have the potential to provide researchers and clinicians with tools to detect and track this process from an early stage, when interventions to interrupt the disease process may be feasible," Genalyte CSO Martin Gleeson said in a statement.

The T1D panel that was launched today measures autoantibodies to insulin, proinsulin, GAD 65, GAD 67, IA-2 (PTPRN, ICA512), phogrin (PTPRN2, IA-2ß) and ZnT8 (SLC30A8), and provides results in 15 minutes, said Genalyte.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.